NAGLAZYME

Google image searchProduct monograph

Active ingredient

galsulfase, 1 MG/ML

DIN: 02412683

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 5MG/5ML. SINGLE USE VIAL.

Schedule: Schedule D

Company: BIOMARIN PHARMACEUTICAL INC.

Date: 01-JAN-2014

ATC:

Reference brand drug: Naglazyme

Pharmaceutical standard: MFR

Search on Google